DocMorris raises $120M in convertible bonds to refinance 2028 debt
What's the deal? DocMorrisDealroom has a profile for this one. Try Dealroom → is issuing approximately CHF 100 million (about $120 million) in senior unsecured convertible bonds due 2031 through a private placement. The bonds, issued by wholly-owned subsidiary DocMorris Finance B.V. and guaranteed by the company, will fund the early repurchase of its outstanding CHF 49.6 million convertible bonds maturing in August 2028.
Why now? DocMorris is capitalising on recent share price gains to restructure its debt on better terms. The move extends the maturity by 2.6 years, cuts the coupon from 3.0% to between 1.5% and 2.0%, and lifts the conversion price.
The terms: The new bonds carry a denomination of CHF 200,000 each and are expected to be redeemed at par on March 16, 2031. The conversion price is set at a premium of 27.5% to 32.5% above the reference price, based on the volume-weighted average price over three trading days.
What's the endgame? Despite roughly doubling the issue size to CHF 100 million, the new bonds carry only 7.0 million underlying shares, down from 7.6 million on the 2028 bonds. That trims potential dilution by around 0.6 million shares at a higher conversion price.
Where the money goes: Incremental proceeds of around CHF 10 million will be used for general corporate purposes, with the balance funding the repurchase of the 2028 bonds through privately negotiated deals with certain holders.
The signal: The refinancing shows how listed companies use rising valuations to reset debt terms — lower coupons, longer runway, and less dilution — before older obligations come due. For DocMorris, it is a balance-sheet cleanup aimed at supporting what it calls "sustainable and profitable growth."
Read more: ad-hoc-news.de
Image credit: Generated with Gemini
